Antimicrobial resistance challenged with metal-based antimicrobial macromolecules

Biomaterials

Volumn 118, Issue , 2017, Pages 27-50

  Abd El Aziz, Alaa S ^a   Agatemor, Christian ^a   Etkin, Nola ^a  

^a UNIVERSITY OF PRINCE EDWARD ISLAND   (Canada)

Author keywords

Antimicrobial resistance; Contact killing materials; Metal based antimicrobial macromolecules; Metal based antimicrobial polymers; Organometallic antimicrobial compounds

Indexed keywords

BIOCOMPATIBILITY; MACROMOLECULES; METALS; ORGANOMETALLICS;

ANTI-MICROBIAL ACTIVITY; ANTIMICROBIAL COMPOUNDS; ANTIMICROBIAL MATERIALS; ANTIMICROBIAL POLYMERS; ANTIMICROBIAL RESISTANCES; INTRACELLULAR PROTEINS; MACROMOLECULAR ARCHITECTURE; MACROMOLECULAR SCAFFOLDS;

MICROORGANISMS;

ANTIINFECTIVE AGENT; METAL; NANOSHEET; NANOTUBE; METAL NANOPARTICLE;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; BACTERICIDAL ACTIVITY; HUMAN; IC50; INFECTION PREVENTION; LEACHING; MACROMOLECULE; NONHUMAN; PRIORITY JOURNAL; REVIEW; VOLATILIZATION; BACTERIAL PHENOMENA AND FUNCTIONS; CELL SURVIVAL; DOSE RESPONSE; DRUG EFFECTS; PHARMACOLOGY; PHYSIOLOGY; SYNTHESIS; TREATMENT OUTCOME;

ANTI-INFECTIVE AGENTS; BACTERIAL PHYSIOLOGICAL PHENOMENA; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, BACTERIAL; MACROMOLECULAR SUBSTANCES; METAL NANOPARTICLES; METALS; TREATMENT OUTCOME;

EID: 85002522747     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2016.12.002     Document Type: Review

References (110)

1. [1] O'Connell, K.M., Hodgkinson, J.T., Sore, H.F., Welch, M., Salmond, G.P., Spring, D.R., Combating multidrug-resistant bacteria: current strategies for the discovery of novel antibacterials. Angew. Chem. Int. Ed. 52 (2013), 10706–10733.
2. [2] Armstrong, G.L., Conn, L.A., Pinner, R.W., Trends in infectious disease mortality in the United States during the 20th century. JAMA 281 (1999), 61–66.
3. [3] Abraham, E.P., Chain, E., Fletcher, C.M., Gardner, A.D., Heatley, N.G., Jennings, M.A., Florey, H.W., Further observations on penicillin. Lancet 238 (1941), 177–189.
4. [4] Rammelkamp, C.H., Maxon, T., Resistance of Staphylococcus aureus to the action of penicillin. Exp. Biol. Med. 51 (1942), 386–389.
5. [5] Finland, M., Emergence of antibiotic-resistant bacteria. N. Engl. J. Med. 253 (1955), 909–922.
6. [6] Barber, M., Methicillin-resistant staphylococci. J. Clin. Pathol. 14 (1961), 385–393.
7. [7] Centers for Disease Control and Prevention (CDC), Vancomycin-resistant Staphylococcus aureus Pennsylvania, 2002. Morb. Mortal. Wkly. Rep., 51, 2002, 902.
8. [8] Shallcross, L.J., Howard, S.J., Fowler, T., Davies, S.C., Tackling the threat of antimicrobial resistance: from policy to sustainable action. Philos. Trans. R. Soc. B, 370, 2015, 20140082.
9. [9] Kenawy, E., Worley, S., Broughton, R., The chemistry and applications of antimicrobial polymers: a state-of-the-art review. Biomacromolecules 8 (2007), 1359–1384.
10. [10] Hadjesfandiari, N., Yu, K., Mei, Y., Kizhakkedathu, J.N., Polymer brush-based approaches for the development of infection-resistant surfaces. J. Mater. Chem. B 2 (2014), 4968–4978.
11. [11] Yu, K., Lo, J.C., Mei, Y., Haney, E.F., Siren, E., Kalathottukaren, M.T., Hancock, R.E.W., Lange, D., Kizhakkedathu, J.N., Toward infection-resistant surfaces: achieving high antimicrobial peptide potency by modulating the functionality of polymer brush and peptide. ACS Appl. Mater. Interfaces 7 (2015), 28591–28605.
12. [12] Daud, N.M., Bahri, I.F.S., Malek, N.A.N.N., Hermawan, H., Saidin, S., Immobilization of antibacterial chlorhexidine on stainless steel using crosslinking polydopamine film: towards infection resistant medical devices. Colloids Surf. B 145 (2016), 130–139.
13. [13] Pappas, H.C., Phan, S., Yoon, S., Edens, L.E., Meng, X., Schanze, K.S., Whitten, D.G., Keller, D.J., Self-sterilizing, self-cleaning mixed polymeric multifunctional antimicrobial surfaces. ACS Appl. Mater. Interfaces 7 (2015), 27632–27638.
14. [14] Wo, Y., Brisbois, E.J., Bartlett, R.H., Meyerhoff, M.E., Recent advances in thromboresistant and antimicrobial polymers for biomedical applications: just say yes to nitric oxide (NO). Biomater. Sci. 4 (2016), 1161–1183.
15. [15] Francolini, I., Donelli, G., Crisante, F., Taresco, V., Piozzi, A., Antimicrobial polymers for anti-biofilm medical devices: state-of-art and perspectives. Donelli, G., (eds.) Biofilm-based Healthcare-associated Infections, 2015, Springer, New York, 93–117.
16. [16] Siedenbiedel, F., Tiller, J.C., Antimicrobial polymers in solution and on surfaces: overview and functional principles. Polymers 4 (2012), 46–71.
17. [17] Dombroski, J.R., Donaruma, L.G., Razzano, J., Synthetic biologically active polymers IV. N-Acylsulfanilamide-formaldehyde copolymers. J. Med. Chem. 10 (1967), 963–964.
18. [18] Dombroski, J.R., Donaruma, L.G., Razzano, J., Synthetic biologically active polymers V. 4,4'-Diaminodiphenyl sulfone-formaldehyde copolymer. J. Med. Chem. 10 (1967), 964–965.
19. [19] Avrameas, S., Ternynck, T., Biologically active water-insoluble protein polymers I. Their use for isolation of antigens and antibodies. J. Biol. Chem. 242 (1967), 1651–1659.
20. [20] Donaruma, L.G., Razzano, J., Synthetic biologically active polymers III. Sulfapyridineformaldehyde copolymers. J. Med. Chem. 9 (1966), 258–259.
21. [21] Cornell, R.J., Donaruma, L.G., Poly(2-methacryloxytropone). A synthetic biologically active polymer. J. Polym. Sci. 3 (1965), 827–828.
22. [22] Cornell, R.J., Donaruma, L.G., 2-Methacryloxytropones. Intermediates for the synthesis of biologically active polymers. J. Med. Chem. 8 (1965), 388–390.
23. [23] Overberger, C.G., Ferraro, J.J., Bonsignore, P.V., Orttung, F.W., Vorchheimer, N., Polymers containing groups of potential biological activity. Pure Appl. Chem. 4 (1962), 521–540.
24. [24] Weetall, H.H., Weliky, N., Coupling of biologically active molecules to insoluble polymers; antibody on cellulose. BBA Gen. Subj. 107 (1965), 150–152.
25. [25] Kochkin, O.A., Novoderezhkina, I.S., Zubov, P.I., Voronkov, N.A., Biologically active organotin and organolead polymers and copolymers. Fizol. Opt. Akt. Polim. Veshchestva, 1971, 86–102.
26. [26] Barry, N.P., Sadler, P.J., Exploration of the medical periodic table: towards new targets. Chem. Commun. 49 (2013), 5106–5131.
27. [27] Patra, M., Gasser, G., Metzler-Nolte, N., Small organometallic compounds as antibacterial agents. Dalton Trans. 41 (2012), 6350–6358.
28. [28] Gasser, G., Metzler-Nolte, N., The potential of organometallic complexes in medicinal chemistry. Curr. Opin. Chem. Biol. 16 (2012), 84–91.
29. [29] Roner, M.R., Carraher, C.E., Shahi, K., Barot, G., Antiviral activity of metal-containing polymers—organotin and cisplatin-like polymers. Materials 4 (2011), 991–1012.
30. [30] Paladini, F., Pollini, M., Sannino, A., Ambrosio, L., Metal-based antibacterial substrates for biomedical applications. Biomacromolecules 16 (2015), 1873–1885.
31. [31] Li, F., Collins, J.G., Keene, F.R., Ruthenium complexes as antimicrobial agents. Chem. Soc. Rev. 44 (2015), 2529–2542.
32. [32] Carraher, C.E., Naoshima, Y., Nagao, K., Roner, M.R., Zhao, A., Barot, G., Battin, A., Antibacterial, yeast and fungal polymeric materials derived from organotin-containing materials. J. Polym. Mater, 28, 2011, 303.
33. [33] Lemire, J.A., Harrison, J.J., Turner, R.J., Antimicrobial activity of metals: mechanisms, molecular targets and applications. Nat. Rev. Microbiol. 11 (2013), 371–384.
34. [34] Harrison, J.J., Ceri, H., Turner, R.J., Multimetal resistance and tolerance in microbial biofilms. Nat. Rev. Microbiol. 5 (2007), 928–938.
35. [35] Workentine, M.L., Harrison, J.J., Stenroos, P.U., Ceri, H., Turner, R.J., Pseudomonas fluorescens' view of the periodic table. Environ. Microbiol. 10 (2008), 238–250.
36. [36] Wenzel, M., Patra, M., Senges, C.H.R., Ott, I., Stepanek, J.J., Pinto, A., Prochnow, P., Vuong, C., Langklotz, S., Metzler-Nolte, N., Bandow, J.E., Analysis of the mechanism of action of potent antibacterial hetero-tri-organometallic compounds: a structurally new class of antibiotics. ACS Chem. Biol. 8 (2013), 1442–1450.
37. [37] Gubin, S., Smirnova, S., Denisovich, L., Lubovich, A., Redox properties of cyclopentadienylmetal compounds I. Ferrocene, ruthenocene, osmocene. J. Organometal. Chem. 30 (1971), 243–255.
38. [38] Sato, M., Nagata, T., Tanemura, A., Fujihara, T., Kumakura, S., Unoura, K., Synthesis and redox behavior of ruthenocene-terminated oligoenes: characteristic and stable two-electron redox system and lower potential shift of the two-electron oxidation wave with elongating conjugation. Chem. Eur. J. 10 (2004), 2166–2178.
39. [39] Yan, Y., Zhang, J., Qiao, Y., Ganewatta, M., Tang, C., Ruthenocene-containing homopolymers and block copolymers via ATRP and RAFT polymerization. Macromolecules 46 (2013), 8816–8823.
40. [40] Abd-El-Aziz, A.S., Agatemor, C., Etkin, N., Overy, D.P., Kerr, R.G., Redox-active cationic organoiron complex: a promising lead structure for developing antimicrobial agents with activity against Gram-positive pathogens including methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecium. RSC Adv. 5 (2015), 86421–86427.
41. [41] Nguyen, D., Boyer, C., Macromolecular and inorganic nanomaterials scaffolds for carbon monoxide delivery: recent developments and future trends. ACS Biomater. Sci. Eng. 1 (2015), 895–913.
42. [42] Desmard, M., Davidge, K.S., Bouvet, O., Morin, D., Roux, D., Foresti, R., Ricard, J.D., Denamur, E., Poole, R.K., Montravers, P., Motterlini, R., Boczkowski, J., A carbon monoxide-releasing molecule (CORM-3) exerts bactericidal activity against Pseudomonas aeruginosa and improves survival in an animal model of bacteraemia. FASEB J. 23 (2009), 1023–1031.
43. [43] Nobre, L.S., Seixas, J.D., Romao, C.C., Saraiva, L.M., Antimicrobial action of carbon monoxide-releasing compounds. Antimicrob. Agents Chemother. 51 (2007), 4303–4307.
44. [44] Nobre, L.S., Al-Shahrour, F., Dopazo, J., Saraiva, L.M., Exploring the antimicrobial action of a carbon monoxide-releasing compound through whole-genome transcription profiling of Escherichia coli. Microbiology 155 (2009), 813–824.
45. [45] Tavares, A.F., Teixeira, M., Romao, C.C., Seixas, J.D., Nobre, L.S., Saraiva, L.M., Reactive oxygen species mediate bactericidal killing elicited by carbon monoxide-releasing molecules. J. Biol. Chem. 286 (2011), 26708–26717.
46. [46] Nobre, L.S., Jeremias, H., Romão, C.C., Saraiva, L.M., Examining the antimicrobial activity and toxicity to animal cells of different types of CO-releasing molecules. Dalton Trans. 45 (2016), 1455–1466.
47. [47] Keren, I., Wu, Y., Inocencio, J., Mulcahy, L.R., Lewis, K., Killing by bactericidal antibiotics does not depend on reactive oxygen species. Science 339 (2013), 1213–1216.
48. [48] Dixon, S.J., Stockwell, B.R., The role of iron and reactive oxygen species in cell death. Nat. Chem. Biol. 10 (2014), 9–17.
49. [49] Fang, F.C., Antibiotic and ROS linkage questioned. Nat. Biotechnol. 31 (2013), 415–416.
50. [50] Kohanski, M.A., Dwyer, D.J., Collins, J.J., How antibiotics kill bacteria: from targets to networks. Nat. Rev. Microbiol. 8 (2010), 423–435.
51. [51] Liu, Y., Imlay, J.A., Cell death from antibiotics without the involvement of reactive oxygen species. Science 339 (2013), 1210–1213.
52. [52] Imlay, J.A., Diagnosing oxidative stress in bacteria: not as easy as you might think. Curr. Opin. Microbiol. 24 (2015), 124–131.
53. [53] Fang, F.C., Antimicrobial reactive oxygen and nitrogen species: concepts and controversies. Nat. Rev. Microbiol. 2 (2004), 820–832.
54. [54] Nathan, C., Cunningham-Bussel, A., Beyond oxidative stress: an immunologist's guide to reactive oxygen species. Nat. Rev. Immunol. 13 (2013), 349–361.
55. [55] West, J.D., Marnett, L.J., Endogenous reactive intermediates as modulators of cell signaling and cell death. Chem. Res. Toxicol. 19 (2006), 173–194.
56. 60) exerts antibacterial effects via ROS-independent protein oxidation. Environ. Sci. Technol. 42 (2008), 8127–8132.
57. [57] Li, J., Wang, G., Zhu, H., Zhang, M., Zheng, X., Di, Z., Liu, X., Wang, X., Antibacterial activity of large-area monolayer graphene film manipulated by charge transfer. Sci. Rep., 4, 2014, 4359.
58. [58] Liu, S., Zeng, T.H., Hofmann, M., Burcombe, E., Wei, J., Jiang, R., Kong, J., Chen, Y., Antibacterial activity of graphite, graphite oxide, graphene oxide, and reduced graphene oxide: membrane and oxidative stress. ACS Nano 5 (2011), 6971–6980.
59. 60) is not due to ROS-mediated damage. Nano Lett. 8 (2008), 1539–1543.
60. [60] Chen, J., Wang, X., Han, H., A new function of graphene oxide emerges: inactivating phytopathogenic bacterium Xanthomonas oryzae pv. Oryzae. J. Nanopart. Res. 15 (2013), 1658–1672.
61. [61] Zou, X., Zhang, L., Wang, Z., Luo, Y., Mechanisms of the antimicrobial activities of graphene materials. J. Am. Chem. Soc. 138 (2016), 2064–2077.
62. [62] Imlay, J.A., Pathways of oxidative damage. Annu. Rev. Microbiol. 57 (2003), 395–418.
63. [63] Zhang, J., Chen, Y.P., Miller, K.P., Ganewatta, M.S., Bam, M., Yan, Y., Nagarkatti, M., Decho, A.W., Tang, C., Antimicrobial metallopolymers and their bioconjugates with conventional antibiotics against multidrug-resistant bacteria. J. Am. Chem. Soc. 136 (2014), 4873–4876.
64. [64] Drawz, S.M., Bonomo, R.A., Three decades of β-lactamase inhibitors. Clin. Microbiol. Rev. 23 (2010), 160–201.
65. [65] Abd-El-Aziz, A.S., Agatemor, C., Etkin, N., Overy, D.P., Lanteigne, M., McQuillan, K., Kerr, R.G., Antimicrobial organometallic dendrimers with tunable activity against multidrug-resistant bacteria. Biomacromolecules 16 (2015), 3694–3703.
66. [66] Fan, Y., Liu, R., Du, W., Lu, Q., Pang, H., Gao, F., Synthesis of copper(II) coordination polymers and conversion into CuO nanostructures with good photocatalytic, antibacterial and lithium ion battery performances. J. Mater. Chem. 22 (2012), 12609–12617.
67. [67] Xu, J., Feng, X., Chen, P., Gao, C., Development of an antibacterial copper(II)-chelated polyacrylonitrile ultrafiltration membrane. J. Membr. Sci. 413 (2012), 62–69.
68. [68] Hassan, E.A., Hassan, M.L., Moorefield, C.N., Newkome, G.R., New supramolecular metallo-terpyridine carboxymethyl cellulose derivatives with antimicrobial properties. Carbohydr. Polym. 116 (2015), 2–8.
69. [69] Lu, X., Luo, Y., Lu, C., Chen, X., Zhang, H., Assembly of three new POM-based Ag(I) coordination polymers with antibacterial and photocatalytic properties. J. Solid State Chem. 232 (2015), 123–130.
70. [70] Lu, X., Ye, J., Sun, Y., Bogale, R.F., Zhao, L., Tian, P., Ning, G., Ligand effects on the structural dimensionality and antibacterial activities of silver-based coordination polymers. Dalton Trans. 43 (2014), 10104–10113.
71. [71] Beheshti, A., Babadi, S.S., Nozarian, K., Heidarizadeh, F., Ghamari, N., Mayer, P., Motamedi, H., Crystal structure, microbiological activity and theoretical studies of Ag(I) and Cu(I) coordination polymers with 1,1′-(butane-1,4-diyl) bis(3-methylimidazoline-2-thione) ligand. Polyhedron 110 (2016), 261–273.
72. [72] Jaros, S.W., Guedes da Silva, M.F.C., Florek, M., Smoleński, P., Pombeiro, A.J., Kirillov, A.M., Silver(I) 1,3,5-Triaza-7-phosphaadamantane coordination polymers driven by substituted glutarate and malonate building blocks: self-assembly synthesis, structural features, and antimicrobial properties. Inorg. Chem. 55 (2016), 5886–5894.
73. 2Cu}n) compounds containing bidentate phosphanes as active antimicrobial agents. Chem. Eur. J. 18 (2012), 3659–3674.
74. [74] Carraher, C.E., Scott, W.J., Schroeder, J.A., Giron, D.J., Poly(cis-dihaiodiamine platinum(II)) compounds: synthesis and biological activity. J. Macromol. Sci. Chem. 15 (1981), 625–631.
75. [75] Carraher, C.E., Lopez, I., Giron, D.J., Polymeric platinol derivative of methotrexate for the treatment of virally related juvenile diabetes. Gebelein, C.G., (eds.) Advances in Biomedical Polymers, 1987, Plenum Press, New York, 311–324.
76. [76] Roner, M.R., Carraher, C.E., Dhanji, S., Barot, G., Antiviral and anticancer activity of cisplatin derivatives of tilorone. J. Inorg. Organometal. Polym. Mater 18 (2008), 374–383.
77. [77] Carraher, C.E., Sabir, T.S., Roner, M.R., Shahi, K., Bleicher, R.E., Roehr, J.L., Bassett, K.D., Synthesis of organotin polyamine ethers containing acyclovir and their preliminary anticancer and antiviral activity. J. Inorg. Organometal. Polym. Mater. 16 (2006), 249–257.
78. [78] Barot, G., Roner, M.R., Naoshima, Y., Nagao, K., Shahi, K., Carraher, C.E., Synthesis, structural characterization, and preliminary biological characterization of organotin polyethers derived from hydroquinone and substituted hydroquinones. J. Inorg. Organometal. Polym. Mater. 19 (2009), 12–27.
79. [79] Andrews, N.C., Disorders of iron metabolism. N. Engl. J. Med. 341 (1999), 1986–1995.
80. [80] Papanikolaou, G., Pantopoulos, K., Iron metabolism and toxicity. Toxicol. Appl. Pharmacol. 202 (2005), 199–211.
81. [81] Van Staveren, D.R., Metzler-Nolte, N., Bioorganometallic chemistry of ferrocene. Chem. Rev. 104 (2004), 5931–5986.
82. [82] Dubar, F., Bohic, S., Dive, D., Guérardel, Y., Cloetens, P., Khalife, J., Biot, C., Deciphering the resistance-counteracting functions of ferroquine in Plasmodium falciparum-infected erythrocytes. ACS Med. Chem. Lett. 3 (2012), 480–483.
83. [83] Dubar, F., Bohic, S., Slomianny, C., Morin, J., Thomas, P., Kalamou, H., Guérardel, Y., Cloetens, P., Khalife, J., Biot, C., In situ nanochemical imaging of label-free drugs: a case study of antimalarials in Plasmodium falciparum-infected erythrocytes. Chem. Commun. 48 (2012), 910–912.
84. [84] Wells, T.N., van Huijsduijnen, R.H., Ferroquine: welcome to the next generation of antimalarials. Lancet Infect. Dis. 15 (2015), 1365–1366.
85. [85] Dubar, F., Slomianny, C., Khalife, J., Dive, D., Kalamou, H., Guérardel, Y., Grellier, P., Biot, C., The ferroquine antimalarial conundrum: redox activation and reinvasion inhibition. Angew. Chem. Int. Ed. 52 (2013), 7690–7693.
86. [86] Lozano-Cruz, T., Ortega, P., Batanero, B., Copa-Patiño, J.L., Soliveri, J., Javier de la Mata, F., Gomez, F., Synthesis, characterization and antibacterial behavior of water-soluble carbosilane dendrons containing ferrocene at the focal point. Dalton Trans. 44 (2015), 19294–19304.
87. [87] Abd-El-Aziz, A.S., Abdelghani, A.A., El-Sadany, S.K., Overy, D.P., Kerr, R.G., Antimicrobial and anticancer activities of organoiron melamine dendrimers capped with piperazine moieties. Eur. Polym. J., 2016, 10.1016/j.europolymj.2016.04.002.
88. [88] Abd-El-Aziz, A.S., Abdelghani, A.A., Pearson, J.K., Awad, M.K., Overy, D.P., Kerr, R.G., Design of piperazine organoiron macromolecules with antibacterial and anticancer activity. Macromol. Chem. Phys. 217 (2016), 987–996.
89. [89] Gul, A., Akhter, Z., Siddiq, M., Sarfraz, S., Mirza, B., Ferrocene-based aliphatic and aromatic poly(azomethine) esters: synthesis, physicochemical studies, and biological evaluation. Macromolecules 46 (2013), 2800–2807.
90. [90] Gul, A., Sarfraz, S., Akhter, Z., Siddiq, M., Kalsoom, S., Perveen, F., Ansari, F.L., Mirza, B., Synthesis, characterization and biological evaluation of ferrocene based poly(azomethene) esters. J. Organometal. Chem. 779 (2015), 91–99.
91. [91] Zhang, J., Yan, J., Pageni, P., Yan, Y., Wirth, A., Chen, Y., Qiao, Y., Wang, Q., Decho, A.W., Tang, C., Anion-responsive metallopolymer hydrogels for healthcare applications. Sci. Rep., 5, 2015, 11914.
92. [92] Engler, A.C., Wiradharma, N., Ong, Z.Y., Coady, D.J., Hedrick, J.L., Yang, Y., Emerging trends in macromolecular antimicrobials to fight multi-drug-resistant infections. Nano Today 7 (2012), 201–222.
93. [93] Nederberg, F., Zhang, Y., Tan, J.P., Xu, K., Wang, H., Yang, C., Gao, S., Guo, X.D., Fukushima, K., Li, L., Hedrick, J.L., Yang, Y.-Y., Biodegradable nanostructures with selective lysis of microbial membranes. Nat. Chem. 3 (2011), 409–414.
94. [94] Dwyer, F.P., Gyarfas, E.C., Roger, W.P., Koch, J.H., Biological activity of complex ions. Nature 170 (1952), 190–191.
95. [95] Dwyer, F.P., Mayhew, E., Roe, E.M.F., Shulman, A., Inhibition of Landschuetz ascites tumor growth by metal chelates derived from 3,4,7,8-tetramethyl-1,10-phenanthroline. Br. J. Cancer 19 (1965), 195–199.
96. [96] Gorle, A.K., Feterl, M., Warner, J.M., Wallace, L., Keene, F.R., Collins, J.G., Tri-and tetra-nuclear polypyridyl ruthenium (ii) complexes as antimicrobial agents. Dalton Trans. 43 (2014), 16713–16725.
97. [97] Li, F., Mulyana, Y., Feterl, M., Warner, J.M., Collins, J.G., Keene, F.R., The antimicrobial activity of inert oligonuclear polypyridylruthenium(II) complexes against pathogenic bacteria, including MRSA. Dalton Trans. 40 (2011), 5032–5038.
98. [98] Gorle, A.K., Feterl, M., Warner, J.M., Primrose, S., Constantinoiu, C.C., Keene, F.R., Collins, J.G., Mononuclear polypyridylruthenium(II) complexes with high membrane permeability in Gram-negative bacteria - in particular Pseudomonas aeruginosa. Chem. Eur. J. 21 (2015), 10472–10481.
99. [99] Wegiel, B., Larsen, R., Gallo, D., Chin, B.Y., Harris, C., Mannam, P., Kaczmarek, E., Lee, P., Zuckerbraun, B.S., Flavell, R., Soares, M.P., Otterbein, L.E., Macrophages sense and kill bacteria through carbon monoxide–dependent inflammasome activation. J. Clin. Investig. 124 (2014), 4926–4940.
100. [100] Nguyen, D., Nguyen, T., Rice, S.A., Boyer, C., CO-Releasing polymers exert antimicrobial activity. Biomacromolecules 16 (2015), 2776–2786.
101. [101] Joyner, J.C., Hodnick, W., Cowan, A.S., Tamuly, D., Boyd, R., Cowan, J., Antimicrobial metallopeptides with broad nuclease and ribonuclease activity. Chem. Commun. 49 (2013), 2118–2120.
102. [102] Chantson, J.T., Falzacappa, M.V.V., Crovella, S., Metzler-Nolte, N., Antibacterial activities of ferrocenoyl-and cobaltocenium-peptide bioconjugates. J. Organometal. Chem. 690 (2005), 4564–4572.
103. [103] Chantson, J.T., Falzacappa, M.V.V., Crovella, S., Metzler-Nolte, N., Solid-phase synthesis, characterization, and antibacterial activities of metallocene–peptide bioconjugates. ChemMedChem. 1 (2006), 1268–1274.
104. [104] Noor, F., Wüstholz, A., Kinscherf, R., Metzler-Nolte, N., A cobaltocenium-peptide bioconjugate shows enhanced cellular uptake and directed nuclear delivery. Angew. Chem. Int. Ed. 44 (2005), 2429–2432.
105. [105] Albada, H.B., Chiriac, A., Wenzel, M., Penkova, M., Bandow, J.E., Sahl, H., Metzler-Nolte, N., Modulating the activity of short arginine-tryptophan containing antibacterial peptides with N-terminal metallocenoyl groups. Beilstein J. Org. Chem. 8 (2012), 1753–1764.
106. [106] Albada, H.B., Prochnow, P., Bobersky, S., Bandow, J.E., Metzler-Nolte, N., Highly active antibacterial ferrocenoylated or ruthenocenoylated Arg-Trp peptides can be discovered by an l-to-d substitution scan. Chem. Sci. 5 (2014), 4453–4459.
107. [107] Hoffknecht, B.C., Prochnow, P., Bandow, J.E., Metzler-Nolte, N., Influence of metallocene substitution on the antibacterial activity of multivalent peptide conjugates. J. Inorg. Biochem. 160 (2016), 246–249.
108. 3 moiety in the activity against gram-positive pathogens including MRSA. Chem. Sci. 6 (2015), 214–224.
109. [109] Pagliarani, A., Nesci, S., Ventrella, V., Toxicity of organotin compounds: shared and unshared biochemical targets and mechanisms in animal cells. Toxicol. Vitro 27 (2013), 978–990.
110. [110] Graceli, J.B., Sena, G.C., Lopes, P.F.I., Zamprogno, G.C., Barcellos da Costa, M., Go, A.F.L., Moscardi dos Santos, D., Rodrigues de Marchi, M.R., Fernandez, M.A., Reprod. Toxicol. 36 (2013), 40–52.